{"id":385999,"date":"2022-03-30T00:00:00","date_gmt":"2022-03-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360cr0035-medtech-cardiac-rhythm-management-devices-market-insights-asia-pacific-supplemental-2021\/"},"modified":"2026-04-17T05:04:01","modified_gmt":"2026-04-17T05:04:01","slug":"m360cr0035-medtech-cardiac-rhythm-management-devices-market-insights-asia-pacific-supplemental-2021","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360cr0035-medtech-cardiac-rhythm-management-devices-market-insights-asia-pacific-supplemental-2021\/","title":{"rendered":"Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2021"},"content":{"rendered":"<p>The Asia Pacific market for\u00a0CRM\u00a0devices will\u00a0expand\u00a0through 2029, driven primarily by an aging population,\u00a0the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. The uptake of premium-priced devices such as\u00a0MRI-conditional devices, leadless pacemakers, and\u00a0S-ICDs will also boost revenues. However, the\u00a0COVID-19\u00a0global pandemic will have a negative impact on the Asia Pacific\u00a0CRM\u00a0device market, resulting in lost procedure volumes in the short term followed by a period of recovery.<\/p>\n<p>This\u00a0Medtech 360 Report\u00a0provides key market metrics for the\u00a0\u00a0CRM\u00a0devices\u00a0in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-385999","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiac-rhythm-management-devices","medtech-geography-asia-pacific","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385999\/revisions"}],"predecessor-version":[{"id":387508,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385999\/revisions\/387508"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}